These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3069176)

  • 21. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin pharmacokinetics after intravenous and oral administration in patients with Crohn's disease.
    Brynskov J; Freund L; Campanini MC; Kampmann JP
    Scand J Gastroenterol; 1992 Nov; 27(11):961-7. PubMed ID: 1455195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin as initial treatment for Crohn's disease.
    Nicholls S; Domizio P; Williams CB; Dawnay A; Braegger CP; MacDonald TT; Walker-Smith JA
    Arch Dis Child; 1994 Sep; 71(3):243-7. PubMed ID: 7979499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of cyclosporin A (Sandimmun) and clinical experience in inflammatory bowel diseases.
    Feutren G; von Graffenried B
    Schweiz Med Wochenschr; 1991 May; 121(20):748-53. PubMed ID: 2057741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budesonide for maintenance of remission in Crohn's disease.
    Simms L; Steinhart AH
    Cochrane Database Syst Rev; 2001; (1):CD002913. PubMed ID: 11279777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
    Hanauer SB; Smith MB
    Am J Gastroenterol; 1993 May; 88(5):646-9. PubMed ID: 8480725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.
    Cortot A; Colombel JF; Rutgeerts P; Lauritsen K; Malchow H; Hämling J; Winter T; Van Gossum A ; Persson T; Pettersson E
    Gut; 2001 Feb; 48(2):186-90. PubMed ID: 11156638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease.
    Sawyerr AM; Wakefield AJ; Hudson M; Dhillon AP; Pounder RE
    Aliment Pharmacol Ther; 1991 Feb; 5(1):1-14. PubMed ID: 1681952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe bone pain as an adverse effect of cyclosporin therapy for Crohn's disease.
    Isaacs KL
    Inflamm Bowel Dis; 1998 May; 4(2):95-7. PubMed ID: 9589296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group.
    Gross V; Andus T; Ecker KW; Raedler A; Loeschke K; Plauth M; Rasenack J; Weber A; Gierend M; Ewe K; Schölmerich J
    Gut; 1998 Apr; 42(4):493-6. PubMed ID: 9616309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Follow up of Crohn's disease under therapy with hydro-MRI].
    Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
    Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine in Crohn's disease.
    N Engl J Med; 1990 Mar; 322(9):636-7. PubMed ID: 2406605
    [No Abstract]   [Full Text] [Related]  

  • 37. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
    Löfberg R; Rutgeerts P; Malchow H; Lamers C; Danielsson A; Olaison G; Jewell D; Ostergaard Thomsen O; Lorenz-Meyer H; Goebell H; Hodgson H; Persson T; Seidegård C
    Gut; 1996 Jul; 39(1):82-6. PubMed ID: 8881815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.
    Schreiber S; Howaldt S; Raedler A
    Gut; 1994 Aug; 35(8):1081-5. PubMed ID: 7926910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.